Breast cancer, a complex disease with various subtypes, presents challenges in treatment response. A study by scientists at the National University of Singapore reveals that the protein Gα13, previously associated with cancer growth, actually inhibits ER-positive breast cancer proliferation by regulating the MYC oncogene. This discovery offers new insights into potential therapies for recurrent ER+ breast cancers and underscores the importance of understanding molecular pathways in specific contexts.
Full Article
Loading PerspectiveSplit analysis...

